<DOC>
	<DOC>NCT01056315</DOC>
	<brief_summary>This trial is assessing the analgesic efficacy and safety of a new central analgesic in subjects with pain due to diabetic peripheral neuropathy (DPN).</brief_summary>
	<brief_title>A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Symmetrical painful diabetic peripheral neuropathy History of hypersensitivity, allergy or contraindication to opioids and acetaminophen Confounding painful conditions Significant vascular disease History or risk of seizure Chronic disease that might effect drug absorption, distribution, metabolism, or excretion Female subjects who are being pregnant or breastfeeding Evidence or history of alcohol, medication, or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Analgesia</keyword>
	<keyword>Diabetic Neuropathy</keyword>
	<keyword>Neuropathic pain</keyword>
	<keyword>Painful</keyword>
	<keyword>Chronic pain</keyword>
</DOC>